Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efflux-mediated antimicrobial resistance.

Keith Poole1

  • 1Department of Microbiology & Immunology, Queen's University, Kingston, ON, Canada. poolek@post.queensu.ca

The Journal of Antimicrobial Chemotherapy
|May 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum for Lehotsky et al., "Lysine polyphosphate modifications contribute to virulence factors in <i>Pseudomonas aeruginosa</i>".

mBio·2025
Same author

Lysine polyphosphate modifications contribute to virulence factors in <i>Pseudomonas aeruginosa</i>.

mBio·2025
Same author

The aminoglycoside resistance-promoting AmgRS envelope stress-responsive two-component system in Pseudomonas aeruginosa is zinc-activated and protects cells from zinc-promoted membrane damage.

Microbiology (Reading, England)·2019
Same author

Structure-guided disruption of the pseudopilus tip complex inhibits the Type II secretion in Pseudomonas aeruginosa.

PLoS pathogens·2018
Same author

Aminoglycoside-inducible expression of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: Involvement of the envelope stress-responsive AmgRS two-component system.

PloS one·2018
Same author

Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.

The Journal of antimicrobial chemotherapy·2018
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Antibiotic resistance is a major challenge. Efflux pumps, which export substances from cells, contribute to resistance against both antibiotics and biocides, impacting treatment strategies.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Resistance

Background:

  • Antibiotic resistance poses a significant threat to infectious disease treatment.
  • Reduced susceptibility to biocides is observed, necessitating consideration of their history in antibiotic resistance.
  • Efflux mechanisms are key determinants of intrinsic and acquired resistance to antimicrobials and biocides.

Purpose of the Study:

  • To review the role of efflux mechanisms in antimicrobial and biocide resistance.
  • To discuss the implications of efflux systems in the development of resistance.
  • To highlight the importance of considering efflux in strategies for treating drug-resistant infections.

Main Methods:

  • Literature review and analysis of existing research on efflux mechanisms.

Related Experiment Videos

  • Examination of genetic encoding and regulation of efflux pumps.
  • Discussion of the clinical significance and potential therapeutic targeting of efflux systems.

    • Main Results:

    • Efflux mechanisms, both drug-specific and multidrug, are critical for resistance.
    • Some efflux systems can transport both antibiotics and biocides, raising concerns about cross-resistance.
    • Multidrug efflux mechanisms are often chromosome-encoded and regulated by gene mutations, while drug-specific ones are frequently plasmid-encoded.

    Conclusions:

    • Efflux plays a crucial role in both antibiotic and biocide resistance.
    • Understanding efflux mechanisms is vital for developing new antimicrobial agents and strategies to overcome resistance.
    • Targeting efflux pumps directly or designing efflux-resistant drugs are potential therapeutic approaches.